Trial Profile
Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children: Prospective, Multi-center, Randomize, Parallel Group Placebo Controlled Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2021
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary) ; Amoxicillin/clavulanic acid
- Indications Diarrhoea
- Focus Therapeutic Use
- Acronyms PEARL
- 11 Feb 2021 Status changed from recruiting to completed.
- 07 Feb 2019 Planned End Date changed from 1 Sep 2018 to 1 Jan 2020.
- 07 Feb 2019 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2019.